A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ...

These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same? They might be on ...

The trial featured two California women who developed ovarian cancer after decades of using the company's talc-based baby powder products. The award to plaintiffs Monica Kent and Deborah Schultz, and ...

The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...

Johnson & Johnson MedTech (NYSE:JNJ) is enacting an organizational restructuring, changing the way its business units operate ...

A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause ...

It is that time of the fantasy season where we do not keep up with the Jones' but the Johnson's instead. Here is the latest ...

Johnson & Johnson stock nears $200 after rally. Find out why analysts maintain a Hold rating on JNJ stock and a $220 price ...

Johnson & Johnson was ordered to pay $966 million to the family of a woman who alleged the New Brunswick-headquartered health giant’s talcum-based baby powder gave her a fatal cancer. Following a ...

Johnson & Johnson’s failed attempts to resolve a mountain of talcum powder lawsuits through class-action bankruptcy settlements have left the company with the daunting prospect of litigating cases ...

The New York Jets have agreed to a multi-year sponsorship with Johnson & Johnson to promote better health to Jets fans, making them the team's Official Medical Innovation Sponsor. Johnson & Johnson ...